US WorldMeds Announces Partnership With FEMA And Healthcare Ready During Coronavirus Pandemic
Retrieved on:
Thursday, July 9, 2020
LOUISVILLE, Ky., July 9, 2020 /PRNewswire/ --USWM LLC dba US WorldMeds (USWM), a Kentucky-based company, has today announced their partnership with the Federal Emergency Management Agency (FEMA) and Healthcare Ready in bringing urgently needed opioid withdrawal medication to communities in need during the current coronavirus pandemic.
Key Points:
- LOUISVILLE, Ky., July 9, 2020 /PRNewswire/ --USWM LLC dba US WorldMeds (USWM), a Kentucky-based company, has today announced their partnership with the Federal Emergency Management Agency (FEMA) and Healthcare Ready in bringing urgently needed opioid withdrawal medication to communities in need during the current coronavirus pandemic.
- While not a treatment for OUD, LUCEMYRA is the only non-opioid medication approved by the FDA for treatment of opioid withdrawal symptoms*.
- *LUCEMYRA will not completely prevent the symptoms of opioid withdrawal and is not a treatment for Opioid Use Disorder.
- COVID has highlighted how left behind our patients have been in the pandemic with substance use disorder rates rising.